Previously, we have shown that expression of Zeb2 from the R26-promoter in hematopoietic precursors is sufficient to induce immature T-ALL in mice34, justifying the use of the R26-promoter to drive subtle and more physiological overexpression of putative oncogenes in vivo. The gene discussed is ZEB2; the disease is acute lymphoblastic leukemia.